Emmes Acquires UK-Based Orphan Reach
May 11, 2021
Emmes, a global full-service CRO and portfolio company of Behrman Capital, acquired Orphan Reach, a UK-based CRO specialized in rare-disease clinical research. The add-on expands Emmes' geographic footprint and rare-disease capabilities; Orphan Reach's founder and management will remain in place and financial terms were not disclosed.
- Buyers
- Emmes, Behrman Capital
- Targets
- Orphan Reach
- Platforms
- Emmes
- Industry
- Healthcare Services
- Location
- England, United Kingdom
- Transaction Type
- Addon
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.